Table 2 Univariate meta-regression analysis results of HbA1c change.

From: Glucagon-like peptide-1 mimetics, optimal for Asian type 2 diabetes patients with and without overweight/obesity: meta-analysis of randomized controlled trials

 

Estimate

95% CI

p value

Treatment duration

0.020

(−0.004, 0.043)

0.104

Diabetes duration

−0.083

(−0.136, −0.030)

0.003

Age

−0.012

(−0.047, 0.022)

0.466

Female percentage

0.041

(0.015, 0.066)

0.003

Baseline HbA1c level

0.070

(−0.493, 0.634)

0.800

Sample size

0.002

(0.000, 0.003)

0.026

Study with statistical significance

−0.855

(−1.364, −0.347)

0.002

Study with GLP−1RA versus placebo

−0.825

(−1.153, −0.496)

0.000

  1. CI, confidence interval; GLP−1RA, glucagon-like peptide-1 receptor agonist.
Back to article page